AHCO AdaptHealth
- 9.620
- -0.100-1.03%
- 9.600
- -0.020-0.21%
AdaptHealth News
AdaptHealth Corp: Leerink Partners Raises Price Target from $13 to $14
AdaptHealth Corp: Leerink Partners Raises Price Target from $13 to $14
Express News | Adapthealth Corp : Leerink Partners Raises Target Price to $14 From $13
AdaptHealth Corp. to Participate in the UBS Healthcare Services Cape Cod Summit
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
AdaptHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
AdaptHealth Corp. to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services,
AdaptHealth Growth Concerns Prompt Underperform Rating Amid Operational Challenges
Breaking Down AdaptHealth: 4 Analysts Share Their Views
AdaptHealth (NASDAQ:AHCO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise overview of rec
AdaptHealth Is Maintained at Buy by Truist Securities
AdaptHealth Is Maintained at Buy by Truist Securities
Truist Securities Maintains Buy on AdaptHealth, Maintains $13 Price Target
Truist Securities analyst David Macdonald maintains AdaptHealth with a Buy and maintains $13 price target.
AdaptHealth Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 31.05% Truist Securities $13 → $13 Maintains Buy 03/04/2024 31.05% RBC Capital → $13 Reiterates
Analysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)
AdaptHealth First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AdaptHealth Corp. (NASDAQ:AHCO) Q1 2024 Earnings Call Transcript
AdaptHealth Corp. to Participate in the BofA Securities 2024 Health Care Conference
Underperform Rating Due to AdaptHealth's Mixed Financial Outlook and Operational Hurdles
AdaptHealth Corp (AHCO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue and EBITDA ...
AdaptHealth | 10-Q: Quarterly report
Adapthealth Corporation (AHCO) Q1 2024 Earnings Call Transcript
Adapthealth Corporation (AHCO) Q1 2024 Earnings Call Transcript
AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast
AdaptHealth (AHCO) shares were down nearly 8.7% in recent Tuesday trading after the company posted a Q1 net loss that missed analysts' earnings expectations. The company reported a Q1 net loss of $0.0
AdaptHealth Corp Reports Mixed Q1 2024 Results: Revenue Up, Net Loss Recorded
Analysis
Price Target
No Data
